Pamidronate for pain control in patients with malignant osteolytic bone disease: a prospective dose-effect study
Thürlimann B, Morant R, Jungi W, Radziwill A. Pamidronate for pain control in patients with malignant osteolytic bone disease: a prospective dose-effect study. Support Care Cancer 1994; 2:61-5.
Jan 1, 1994
Pamidronate for pain control in patients with malignant osteolytic bone disease: a prospective dose-effect study
Jan 1, 1994
Support Care Cancer 1994; 2:61-5
Thürlimann Beat, Morant R, Jungi W F, Radziwill A
more
